James Andrea S. — SEC Form 4 filings
SEC reporting owner CIK 2027010. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-30.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-24 to 2026-03-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 151,231 shares, $345,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 97,561 shares @ $2.05 ($200,000) in Insight Molecular Diagnostics Inc., filed 2025-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | Chief Financial Officer | 10 | 3 legs · 151,231 sh · $345,800 | — | 14 |
Form 4 filings — James Andrea S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-30 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Option exercise (M): 28,302 · Tax withholding (F): 11,298 @ $4.11 · Option exercise (M): 28,302 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4/A | Insight Molecular Diagnostics Inc. (IMDX) | Option exercise (M): 50,000 @ $0 · Tax withholding (F): 12,175 @ $6.01 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Option exercise (M): 50,000 @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Oncocyte Corp (OCX) | Grant/award (A): 113,207 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Oncocyte Corp (OCX) | Purchase (P): 97,561 @ $2.05 | EDGAR |
| 2024-12-09 | 4 | Oncocyte Corp (OCX) | Purchase (P): 20,000 @ $2.29 | EDGAR |
| 2024-10-15 | 4 | Oncocyte Corp (OCX) | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Oncocyte Corp (OCX) | Purchase (P): 33,670 @ $2.97 | EDGAR |
| 2024-06-24 | 4 | Oncocyte Corp (OCX) | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2027010 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →